Drug Addiction Alcohol Consumption Drug Use Alcoholism Addiction Alcohol Opioid Crisis Fentanyl Crisis Mental Health Doping in Sports Nitrous Oxide Drug Overdose Drug Policy Fentanyl Drug Awareness Doping Illicit Drugs Recreational Drugs Harm Reduction Drug Abuse Drugs Drug-Free Initiatives Drug Trafficking Alcohol Abuse Recovery Alcohol Addiction Inhalants Tobacco Use Drug Prevention Awareness Campaigns Public Health Drug Testing Public Perception Captagon Amphetamines Youth Issues Drug Overdoses Alcohol Intoxication Drug Rehabilitation Recovery Programs Drug Deaths Prevention Illicit Liquor Overdose Deaths Community Support Drug Bans Overdose Vaping and Drugs Youth Drug Consumption Tobacco Drug Production Opioid Dependence Cannabis K.O.-Tropfen Cocaine Opioid Addiction Spiking Overdoses Treatment Programs Performance Enhancers Public Health Risks Treatment Options Addiction Treatment Accidental Deaths Nitrous Oxide Misuse Performance Enhancing Drugs Crisis Ketamine Therapeutic Measures Alcohol Use Drug Education Crisis Intervention Narcotics Personal Struggles Marijuana Workplace Policies Synthetic Cannabinoids Education Impact on Community Drug Trends Cannabis Use Inhalant Use Epidemic Sobriety Drug Prevention Programs K.o.-Tropfen Drug Awareness Campaigns Opioids Alcohol Safety Prescription Drugs Support Systems Drug Consumption Pharmaceutical Drugs
Prosecutors press lawmakers to create licensing, accredited testing and a 21-plus age limit after lab results showed most “hemp” products were potent marijuana.